Cognisgarp

Lowers blood glucose and offers cardiometabolic protection

Cognisahrp (L Carnosine), a histidine-containing dipeptide (HCD), is synthesised by bonding of the amino acids β-alanine and L-histidine, a reaction catalysed by carnosine synthase. L carnosine is not naturally found in humans.

Carnosine acts as an anti-glycating agent, reducing the rate of formation of advanced glycation end-products. AGEs can be a factor in the development or worsening of many degenerative diseases, such as diabetes, atherosclerosis, chronic kidney failure, and Alzheimer’s disease. Many studies have demonstrated carnosine’s role in metabolic and cardiovascular disorders.

It has been proven to scavenge reactive oxygen species (ROS) as well as alpha-beta unsaturated aldehydes formed from peroxidation of cell membrane fatty acids during oxidative stress. It also buffers pH in muscle cells, and acts as a neurotransmitter in the brain.

Pack Size: 60 Tablets

2,880.00 2,592.00Add to cart

fssai-300px

Pack Size: 60 Tablets

2,880.00 2,592.00Add to cart

fssai-300px

Cognisahrp (L Carnosine), a histidine-containing dipeptide (HCD), is synthesised by bonding of the amino acids β-alanine and L-histidine, a reaction catalysed by carnosine synthase. L carnosine is not naturally found in humans.

Carnosine acts as an anti-glycating agent, reducing the rate of formation of advanced glycation end-products. AGEs can be a factor in the development or worsening of many degenerative diseases, such as diabetes, atherosclerosis, chronic kidney failure, and Alzheimer’s disease. Many studies have demonstrated carnosine’s role in metabolic and cardiovascular disorders.

It has been proven to scavenge reactive oxygen species (ROS) as well as alpha-beta unsaturated aldehydes formed from peroxidation of cell membrane fatty acids during oxidative stress. It also buffers pH in muscle cells, and acts as a neurotransmitter in the brain.

Who benefits from Cognisharp

People with prediabetes and those with uncontrolled diabetes and in post stroke condition to improve cognitive ability.

Cognisharp composition
Each tablet contains 200 mg of L carnosine

Recommended dosage & directions

Usual dosage is 2 tablets daily. May be increased as needed.

Caution: While there are no known serious drug interactions, caution should be exercised in the concomitant use with antihypertensives reporting lowered BP.

Frequent monitoring of BP and blood glucose is therefore recommended as a matter of general precaution to avoid any sudden and unmonitored drops.

It is recommended that you talk to your healthcare professional before taking any supplements and also if you experience any difficulty or have any questions about using Cognisharp